|
Market Closed -
Nasdaq
04:00:00 2026-08-13 pm EDT
|
5-day change | 1st Jan Change | ||
| 0.8241 USD | -5.00% |
|
-1.85% | -27.71% |
| Jul. 20 | Iridex Augments EyeProGPO Product Offering With EndoProbe Handpieces | MT |
| Jul. 13 | Novel Inspiration International Co Ltd Intends to Engage with IRIDEX Corporation | CI |
| Market Cap | 14.34M 12.43M 11.66M 10.63M 20M 1.37B 20.32M 137M 53.58M 685M 53.85M 52.69M 2.29B | P/E 2026 * |
-16.5x | P/E 2027 * | 41.2x |
|---|---|---|---|---|---|
| Enterprise Value | 14.34M 12.43M 11.66M 10.63M 20M 1.37B 20.32M 137M 53.58M 685M 53.85M 52.69M 2.29B | EV / Sales 2026 * |
0.27x | EV / Sales 2027 * | 0.25x |
| Free-Float |
62.93% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: IRIDEX Corporation
| 1 day | -5.00% | ||
| 1 week | -1.85% | ||
| Current month | +0.50% | ||
| 1 month | -22.98% | ||
| 3 months | -19.99% | ||
| 6 months | -40.28% | ||
| Current year | -27.71% |
| 1 week | 0.81 |  | 0.93 |
| 1 month | 0.8 | | 1.1 |
| Current year | 0.8 | | 1.65 |
| 1 year | 0.8 | | 1.65 |
| 3 years | 0.78 | | 3.65 |
| 5 years | 0.78 | | 9.46 |
| 10 years | 0.78 | | 16.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
Patrick Mercer
CEO | Chief Executive Officer | 54 | 2024-09-30 |
Romeo Dizon
DFI | Director of Finance/CFO | 68 | 2018-12-17 |
Philip Taylor
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Scott Shuda
CHM | Chairman | 60 | 2020-06-23 |
Patrick Mercer
BRD | Director/Board Member | 54 | 2018-08-31 |
Beverly A. Huss
BRD | Director/Board Member | 66 | 2022-03-16 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/10/26 | Free | Chief Financial Officer | 200,000 | 1.1490% | ||
| 7/10/26 | Free | Chief Executive Officer | 400,000 | 2.2980% | ||
| 6/13/26 | Tax | Chief Executive Officer | -3,990 | 0.0229% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.00% | -1.85% | -30.16% | -41.10% | 14.34M | |
| -1.18% | +2.74% | +22.92% | +9.58% | 220B | |
| -0.92% | +1.96% | -2.51% | -20.17% | 143B | |
| 0.00% | +7.37% | -16.81% | +31.78% | 142B | |
| +0.53% | +4.85% | -49.57% | +1.29% | 74.91B | |
| -0.53% | +3.63% | +19.16% | +16.56% | 53.35B | |
| +1.28% | -0.23% | -15.73% | -16.32% | 50.13B | |
| +0.71% | +5.62% | +24.11% | +17.68% | 42.16B | |
| -0.63% | +3.46% | +39.31% | +41.78% | 40.63B | |
| +2.09% | +4.95% | -2.04% | +3.07% | 33.33B | |
| Average | -0.10% | +3.35% | -1.13% | +4.42% | 80B | |
| Weighted average by Cap. | -0.06% | +3.84% | +1.71% | +8.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 53M 45.94M 43.07M 39.27M 73.89M 5.06B 75.07M 507M 198M 2.53B 199M 195M 8.45B | 56.77M 49.2M 46.13M 42.06M 79.14M 5.42B 80.4M 543M 212M 2.71B 213M 209M 9.05B |
| Net income | -795K -689K -646K -589K -1.11M -75.87M -1.13M -7.61M -2.97M -37.98M -2.98M -2.92M -127M | 361K 313K 293K 267K 503K 34.45M 511K 3.45M 1.35M 17.25M 1.36M 1.33M 57.53M |
| Net Debt | - | - |
Employees
93
Calendar
Aug. 18
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-13 | $0.8241 | -5.00% | 49,581 |
| 26-08-12 | $0.8675 | -2.51% | 89,266 |
| 26-08-11 | $0.8898 | +5.69% | 74,086 |
| 26-08-10 | $0.8419 | +1.37% | 66,681 |
| 26-08-07 | $0.8305 | -1.08% | 25,300 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.8241USD
Average target price
2.750USD
Spread / Average Target
+233.70%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IRIX Stock
Select your edition
All financial news and data tailored to specific country editions
